Why does troponin I have so many phosphorylation sites? Fact and fancy
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
We discuss a current controversy regarding the relative role of phosphorylation sites on cardiac troponin I (cTnI) (Figure 1) in physiological and patho-physiological cardiac function. Studies with mouse models and in vitro studies indicate that multi-site phosphorylations are involved in both control of maximum tension and sarcomeric responsiveness to Ca2+. Thus one hypothesis is that cardiac function reflects a balance of cTnI phosphorylations and a tilt in this balance may be maladaptive in acquired and genetic disorders of the heart. Studies on human heart samples taken mainly at end stage heart failure, and in depth proteomic analysis of human and rat heart samples demonstrate that Ser23/Ser24 are the major and perhaps the only sites likely to be relevant to control cardiac function. Thus functional significance of Ser23/Ser24 phosphorylation is taken as fact, whereas the function of some other sites is treated as fancy. Maybe the extremes will meet: in any case we both agree that further work needs to be carried out with relatively large mammals and with determination of the time course of changes in phosphorylation to identify transient modifications that may be relevant at a beat-to-beat basis. Moreover, we agree that the changes and effects of cTnI phosphorylation need to be fully integrated into the effects of other phosphorylations in the cardiac myocyte.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiomyocyte stiffness in diastolic heart failure
Borbély, A., van der Velden, J., Papp, Z., Bronzwaer, J. G. F., Edes, I., Stienen, G. J. M., & Paulus, W. J. (2005) · Circulation · doi:10.1161/01.cir.0000155257.33485.6d · Cited by 536 · cited 1×
“I believe our recent studies in cardiac biopsies from patients with an earlier stage of heart failure advanced our understanding of sarcomeric dysfunction as they established the link between increased passive stiffness of sarcomeres and diastolic heart failure [67].”
Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart
SOLARO, R. J., MOIR, A. J. G., & PERRY, S. V. (1976) · Nature · doi:10.1038/262615a0 · Cited by 395 · cited 1×
“1) [5,6], the effect of the phosphorylation to increase the kinetics of Ca2+ exchange with cardiac troponin C [7], and the demonstration of altered contractility in transgenic models with gain or loss of function modifications in the effects of cTnI phosphorylation at these sites [8].”
Self-citationVarian, K. D., Kijtawornrat, A., Gupta, S. C., Torres, C. A. A., Monasky, M. M., Hiranandani, N., Delfin, D. A., Rafael-Fortney, J. A., Periasamy, M., Hamlin, R. L., et al. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.853200 · Cited by 39 · cited 1×
“An increase in heart rate has been shown to change Ca2+-sensitivity and phosphorylation of cTnI [59,60].”
Marston, S. B., & Walker, J. W. (2009) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-009-9184-y · Cited by 16
Cited by
Zhang, J., Guy, M. J., Norman, H. S., Chen, Y.-C., Xu, Q., Dong, X., Guner, H., Wang, S., Kohmoto, T., Young, K. H., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200258m · Cited by 194
Peng, Y., Gregorich, Z. R., Valeja, S. G., Zhang, H., Cai, W., Chen, Y.-C., Guner, H., Chen, A. J., Schwahn, D. J., Hacker, T. A., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.040675 · Cited by 107
Top-down Proteomics: Technology Advancements and Applications to Heart Diseases
Cai, W., Tucholski, T. M., Gregorich, Z. R., & Ge, Y. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1209414 · Cited by 99
“Ser42/44 was identified in vitro and in vitro contractility assays showed that phosphorylation of these sites was detrimental for contractility [99].”
BackgroundAugmented Phosphorylation of Cardiac Troponin I in Hypertensive Heart Failure
Dong, X., Sumandea, C. A., Chen, Y.-C., Garcia-Cazarin, M. L., Zhang, J., Balke, C. W., Sumandea, M. P., & Ge, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.293258 · Cited by 99
Signaling by S-nitrosylation in the heart
Murphy, E., Kohr, M., Menazza, S., Nguyen, T., Evangelista, A., Sun, J., & Steenbergen, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.01.003 · Cited by 82
Metadata
- Authors
- Solaro, R. J., & van der Velden, J.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 48
- Issue
- 5
- Pages
- 810-816
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2087431150
- Cited by
- 66
- References
- 4
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Why does troponin I have so many phosphorylation sites? Fact and fancy. https://app.cochat.ai/papers/10.1016/j.yjmcc.2010.02.014
- The paper
- Solaro, R. J., & van der Velden, J. (2010). Why does troponin I have so many phosphorylation sites? Fact and fancy. Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2010.02.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.